Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[HIV antigen study].

H Reissigl1, P Rosmanith, D Schönitzer

  • 1Zentralinstitut für Bluttransfusion, Chirurgische Univ., Kliniken, Innsbruck, Osterreich.

Beitrage Zur Infusionstherapie = Contributions to Infusion Therapy
|January 1, 1989
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Age and origin of major Smith-Lemli-Opitz syndrome (SLOS) mutations in European populations.

Journal of medical genetics·2007
Same author

Up to 21-day banked red blood cells collected by apheresis and stored for 14 days after automated wash at different times of storage.

Vox sanguinis·2005
Same author

CD4+ and CD8+ mediated cellular immune response to recombinant influenza nucleoprotein.

Vaccine·2002
Same author

Prostate cancer mortality after introduction of prostate-specific antigen mass screening in the Federal State of Tyrol, Austria.

Urology·2001
Same author

The use of the computer cross-match.

Vox sanguinis·2001
Same author

Prolonged iron depletion after allogeneic 2-unit RBC apheresis.

Transfusion·2001
Same journal

[Not Available].

Beitrage zur Infusionstherapie = Contributions to infusion therapy·1993
Same journal

[Preliminary results of the 2nd multicenter study. Thrombocytapheresis with the Fresenius AS-104 blood cell separator and ring study of cell counting. Section of Therapeutic and Preparative Hemapheresis of the DGTI].

Beitrage zur Infusionstherapie = Contributions to infusion therapy·1993
Same journal

[Thrombocyte substitution in hematologic patients].

Beitrage zur Infusionstherapie = Contributions to infusion therapy·1993
Same journal

[Substitution of thrombocyte concentrates in polytransfused patients].

Beitrage zur Infusionstherapie = Contributions to infusion therapy·1993
Same journal

[Indications for fresh frozen plasma: evaluation of virus inactivating preparations].

Beitrage zur Infusionstherapie = Contributions to infusion therapy·1993
Same journal

[Indications for irradiated blood components: dose and side effects].

Beitrage zur Infusionstherapie = Contributions to infusion therapy·1993
See all related articles

This study evaluated the HTLV-III antigen EIA test for routine blood screening to reduce the window period for human immunodeficiency virus (HIV) infection. The research aimed to enhance blood transfusion safety by detecting early-stage HIV infections in donors.

Area of Science:

  • Virology
  • Immunology
  • Public Health

Context:

  • Blood banks in Vienna, Linz, and Innsbruck participated in the field study.
  • The Abbott HTLV-III antigen EIA (Enzyme Immunoassay) was utilized for research purposes.
  • Routine blood transfusion safety is a critical public health concern.

Purpose:

  • To assess the efficacy of the HTLV-III antigen EIA for routine blood transfusion screening.
  • To shorten the diagnostic window for human immunodeficiency virus (HIV) infection.
  • To improve the safety of blood transfusions by detecting early-stage infections.

Summary:

  • The study involved testing blood donors using the HTLV-III antigen EIA, alongside HIV antibody testing.
  • Neopterin serum levels were also measured in donors at the Central Blood Transfusion Institute in Innsbruck.

Related Experiment Videos

  • The goal was to identify newly infected individuals before seroconversion, thus narrowing the 'diagnostic window'.

    • Impact:

    • Potential to significantly enhance the safety of blood supply by detecting infections earlier.
    • Contributes to the understanding of early viral markers in HIV infection.
    • Provides data for the implementation of improved screening protocols in blood banks.